Pulmonary Arterial Stiffness: Toward a New Paradigm in Pulmonary Arterial Hypertension Pathophysiology and Assessment

Current Hypertension Reports

Volumn 18, Issue 1, 2016, Pages 1-13

  Schäfer, Michal ^a   Myers, Cynthia ^a   Brown, R Dale ^a   Frid, Maria G ^a   Tan, Wei ^b   Hunter, Kendall ^a   Stenmark, Kurt R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Extracellular matrix; Imaging; Inflammation; Macrophage; Pulmonary hypertension; Vascular stiffening

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; ELASTIN; GELATINASE B; MACROPHAGE ELASTASE; MATRILYSIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTERIAL STIFFNESS; CARDIOVASCULAR MAGNETIC RESONANCE; CELL PROLIFERATION; CYTOKINE PRODUCTION; DOPPLER ECHOCARDIOGRAPHY; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; LUNG VASCULAR RESISTANCE; MEAN ARTERIAL PRESSURE; MECHANOTRANSDUCTION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN CLEAVAGE; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; REVIEW; SMOOTH MUSCLE FIBER; TRANSTHORACIC ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; HEMODYNAMICS;

ECHOCARDIOGRAPHY; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; PULMONARY ARTERY; VASCULAR STIFFNESS;

EID: 84953321007     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-015-0609-2     Document Type: Review

References (103)

1. Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63(7):636–46. doi:10.1016/j.jacc.2013.09.063.
2. Jain S, Khera R, Corrales-Medina VF, Townsend RR, Chirinos JA. Inflammation and arterial stiffness in humans. Atherosclerosis. 2014;237(2):381–90. doi:10.1016/j.atherosclerosis.2014.09.011.
3. Mitchell GF. Arterial stiffness and hypertension: chicken or egg? Hypertension. 2014;64(2):210–4. doi:10.1161/HYPERTENSIONAHA.114.03449.
4. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121(4):505–11. doi:10.1161/CIRCULATIONAHA.109.886655. Clinical study establishing role of vascular stiffness in cardiovascular outcomes.
5. Mitchell GF, van Buchem MA, Sigurdsson S, Gotal JD, Jonsdottir MK, Kjartansson O, et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility—Reykjavik study. Brain. 2011;134(Pt 11):3398–407. doi:10.1093/brain/awr253.
6. Kelly RP, Tunin R, Kass DA. Effect of reduced aortic compliance on cardiac efficiency and contractile function of in situ canine left ventricle. Circ Res. 1992;71(3):490–502.
7. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension. 2005;46(1):200–4. doi:10.1161/01.HYP.0000168052.00426.65.
8. Hunter KS, Lammers SR, Shandas R. Pulmonary vascular stiffness: measurement, modeling, and implications in normal and hypertensive pulmonary circulations. Comp Physiol. 2011;1(3):1413–35. doi:10.1002/cphy.c100005. Overviews the role of pulmonary stiffness in PH pathophysiology.
9. Lammers S, Scott D, Hunter K, Tan W, Shandas R, Stenmark KR. Mechanics and function of the pulmonary vasculature: implications for pulmonary vascular disease and right ventricular function. Comp Physiol. 2012;2(1):295–319. doi:10.1002/cphy.c100070. Discusses physiologic and pathologic aspects of the RV-PA axis as a mechanically coupled unit.
10. Tan W, Madhavan K, Hunter KS, Park D, Stenmark KR. Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series). Pulm Circ. 2014;4(4):560–80. doi:10.1086/677370.
11. Hunter KS, Lee PF, Lanning CJ, Ivy DD, Kirby KS, Claussen LR, et al. Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension. Am Heart J. 2008;155(1):166–74. doi:10.1016/j.ahj.2007.08.014. Important validation of impedance measurement as PH prognostic indicator.
12. Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol. 2009;297(6):L1013–32. doi:10.1152/ajplung.00217.2009.
13. Stevens GR, Garcia-Alvarez A, Sahni S, Garcia MJ, Fuster V, Sanz J. RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness. JACC Cardiovasc Imaging. 2012;5(4):378–87. doi:10.1016/j.jcmg.2011.11.020.
14. Gan CT, Lankhaar JW, Westerhof N, Marcus JT, Becker A, Twisk JW, et al. Noninvasively assessed pulmonary artery stiffness predicts mortality in pulmonary arterial hypertension. Chest. 2007;132(6):1906–12. doi:10.1378/chest.07-1246.
15. Sanz J, Kariisa M, Dellegrottaglie S, Prat-Gonzalez S, Garcia MJ, Fuster V, et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging. 2009;2(3):286–95. doi:10.1016/j.jcmg.2008.08.007.
16. Wang Z, Chesler NC. Pulmonary vascular wall stiffness: an important contributor to the increased right ventricular afterload with pulmonary hypertension. Pulm Circ. 2011;1(2):212–23. doi:10.4103/2045-8932.83453.
17. Rich S. The current treatment of pulmonary arterial hypertension: time to redefine success. Chest. 2006;130(4):1198–202. doi:10.1378/chest.130.4.1198.
18. Rich S. The value of approved therapies for pulmonary arterial hypertension. Am Heart J. 2007;153(6):889–90. doi:10.1016/j.ahj.2007.03.001.
19. Macchia A, Marchioli R, Marfisi R, Scarano M, Levantesi G, Tavazzi L, et al. A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology. Am Heart J. 2007;153(6):1037–47. doi:10.1016/j.ahj.2007.02.037.
20. Wagenseil JE, Mecham RP. Elastin in large artery stiffness and hypertension. J Cardiovasc Transl Res. 2012;5(3):264–73. doi:10.1007/s12265-012-9349-8.
21. Tsamis A, Krawiec JT, Vorp DA. Elastin and collagen fibre microstructure of the human aorta in ageing and disease: a review. J R Soc Interface. 2013;10(83):20121004. doi:10.1098/rsif.2012.1004.
22. Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):25S–32. doi:10.1016/j.jacc.2004.02.033.
23. Tuder RM, Archer SL, Dorfmuller P, Erzurum SC, Guignabert C, Michelakis E, et al. Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D4–12. doi:10.1016/j.jacc.2013.10.025.
24. Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res. 2006;99(7):675–91. doi:10.1161/01.RES.0000243584.45145.3f.
25. Stankovic Z, Allen BD, Garcia J, Jarvis KB, Markl M. 4D flow imaging with MRI. Cardiovasc Diagn Ther. 2014;4(2):173–92. doi:10.3978/j.issn.2223-3652.2014.01.02.
26. Selvin E, Najjar SS, Cornish TC, Halushka MK. A comprehensive histopathological evaluation of vascular medial fibrosis: insights into the pathophysiology of arterial stiffening. Atherosclerosis. 2010;208(1):69–74. doi:10.1016/j.atherosclerosis.2009.06.025.
27. Rogers NM, Yao M, Sembrat J, George MP, Knupp H, Ross M, et al. Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension. Pulm Circ. 2013;3(4):936–51. doi:10.1086/674754.
28. Lammers SR, Kao PH, Qi HJ, Hunter K, Lanning C, Albietz J, et al. Changes in the structure-function relationship of elastin and its impact on the proximal pulmonary arterial mechanics of hypertensive calves. Am J Physiol Heart Circ Physiol. 2008;295(4):H1451–9. doi:10.1152/ajpheart.00127.2008.
29. Chai S, Chai Q, Danielsen CC, Hjorth P, Nyengaard JR, Ledet T, et al. Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis. Circ Res. 2005;96(5):583–91. doi:10.1161/01.RES.0000158963.37132.8b.
30. Delles C, Zimmerli LU, McGrane DJ, Koh-Tan CH, Pathi VL, McKay AJ, et al. Vascular stiffness is related to superoxide generation in the vessel wall. J Hypertens. 2008;26(5):946–55. doi:10.1097/HJH.0b013e3282f7677c.
31. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest. 1996;98(11):2572–9. doi:10.1172/JCI119076.
32. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol. 2005;25(5):932–43. doi:10.1161/01.ATV.0000160548.78317.29.
33. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002;90(3):251–62.
34. Luft FC. Molecular mechanisms of arterial stiffness: new insights. J Am Soc Hypertens. 2012;6(6):436–8. doi:10.1016/j.jash.2012.10.004.
35. Rabinovitch M, Bothwell T, Hayakawa BN, Williams WG, Trusler GA, Rowe RD, et al. Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. A correlation of light with scanning electron microscopy and transmission electron microscopy. Lab Invest. 1986;55(6):632–53.
36. Wu J, Thabet SR, Kirabo A, Trott DW, Saleh MA, Xiao L, et al. Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase. Circ Res. 2014;114(4):616–25. doi:10.1161/CIRCRESAHA.114.302157.
37. Kanematsu Y, Kanematsu M, Kurihara C, Tada Y, Tsou TL, van Rooijen N, et al. Critical roles of macrophages in the formation of intracranial aneurysm. Stroke. 2011;42(1):173–8. doi:10.1161/STROKEAHA.110.590976.
38. Zhou J, Tang PC, Qin L, Gayed PM, Li W, Skokos EA, et al. CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses. J Exp Med. 2010;207(9):1951–66. doi:10.1084/jem.20100098.
39. Frid MG, Brunetti JA, Burke DL, Carpenter TC, Davie NJ, Reeves JT, et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol. 2006;168(2):659–69. doi:10.2353/ajpath.2006.050599. Significant earlier paper demonstrating recruitment of circulating inflammatory cells to the vessel wall as determinant of remodeling in PH.
40. Schnabel R, Larson MG, Dupuis J, Lunetta KL, Lipinska I, Meigs JB, et al. Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection. Hypertension. 2008;51(6):1651–7. doi:10.1161/HYPERTENSIONAHA.107.105668.
41. Bajpai VK, Mistriotis P, Loh YH, Daley GQ, Andreadis ST. Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. Cardiovasc Res. 2012;96(3):391–400. doi:10.1093/cvr/cvs253.
42. da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells. 2008;26(9):2287–99. doi:10.1634/stemcells.2007-1122.
43. Reilly GC, Engler AJ. Intrinsic extracellular matrix properties regulate stem cell differentiation. J Biomech. 2010;43(1):55–62. doi:10.1016/j.jbiomech.2009.09.009.
44. Suzuki S, Narita Y, Yamawaki A, Murase Y, Satake M, Mutsuga M, et al. Effects of extracellular matrix on differentiation of human bone marrow-derived mesenchymal stem cells into smooth muscle cell lineage: utility for cardiovascular tissue engineering. Cells Tissues Organs. 2010;191(4):269–80. doi:10.1159/000260061.
45. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126(4):677–89. doi:10.1016/j.cell.2006.06.044.
46. Discher DE, Janmey P, Wang YL. Tissue cells feel and respond to the stiffness of their substrate. Science. 2005;310(5751):1139–43. doi:10.1126/science.1116995.
47. Huebsch N, Arany PR, Mao AS, Shvartsman D, Ali OA, Bencherif SA, et al. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater. 2010;9(6):518–26. doi:10.1038/nmat2732.
48. Wingate K, Bonani W, Tan Y, Bryant SJ, Tan W. Compressive elasticity of three-dimensional nanofiber matrix directs mesenchymal stem cell differentiation to vascular cells with endothelial or smooth muscle cell markers. Acta Biomater. 2012;8(4):1440–9. doi:10.1016/j.actbio.2011.12.032.
49. Floren M, Tan W. Three-dimensional, soft neotissue arrays as high throughput platforms for the interrogation of engineered tissue environments. Biomaterials. 2015;59:39–52. doi:10.1016/j.biomaterials.2015.04.036.
50. Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N, et al. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell. 2013;154(5):1047–59. doi:10.1016/j.cell.2013.07.042. Identifies YAP-TAZ as important mechanotrasduction pathway.
51. Calvo F, Ege N, Grande-Garcia A, Hooper S, Jenkins RP, Chaudhry SI, et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol. 2013;15(6):637–46. doi:10.1038/ncb2756. Demonstrates significance of YAP-TAZ signaling in cancer pathophysiology.
52. Liu F, Lagares D, Choi KM, Stopfer L, Marinkovic A, Vrbanac V, et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am J Physiol Lung Cell Mol Physiol. 2015;308(4):L344–57. doi:10.1152/ajplung.00300.2014.
53. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP/TAZ in mechanotransduction. Nature. 2011;474(7350):179–83. doi:10.1038/nature10137.
54. Huang X, Yang N, Fiore VF, Barker TH, Sun Y, Morris SW, et al. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. Am J Respir Cell Mol Biol. 2012;47(3):340–8. doi:10.1165/rcmb.2012-0050OC.
55. Li M, Scott DE, Shandas R, Stenmark KR, Tan W. High pulsatility flow induces adhesion molecule and cytokine mRNA expression in distal pulmonary artery endothelial cells. Ann Biomed Eng. 2009;37(6):1082–92. doi:10.1007/s10439-009-9684-3.
56. Li M, Stenmark KR, Shandas R, Tan W. Effects of pathological flow on pulmonary artery endothelial production of vasoactive mediators and growth factors. J Vasc Res. 2009;46(6):561–71. doi:10.1159/000226224.
57. Li M, Tan Y, Stenmark KR, Tan W. High pulsatility flow induces acute endothelial inflammation through overpolarizing cells to activate NF-kappaB. Cardiovasc Eng Technol. 2013;4(1):26–38. doi:10.1007/s13239-012-0115-5. Demonstrates linkage mechanism between disturbed flow and endothelial inflammatory response.
58. Scott D, Tan Y, Shandas R, Stenmark KR, Tan W. High pulsatility flow stimulates smooth muscle cell hypertrophy and contractile protein expression. Am J Physiol Lung Cell Mol Physiol. 2013;304(1):L70–81. doi:10.1152/ajplung.00342.2012.
59. Scott-Drechsel D, Su Z, Hunter K, Li M, Shandas R, Tan W. A new flow co-culture system for studying mechanobiology effects of pulse flow waves. Cytotechnology. 2012;64(6):649–66. doi:10.1007/s10616-012-9445-2.
60. Su Z, Tan W, Shandas R, Hunter KS. Influence of distal resistance and proximal stiffness on hemodynamics and RV afterload in progression and treatments of pulmonary hypertension: a computational study with validation using animal models. Comp Math Methods Med. 2013;2013:618326. doi:10.1155/2013/618326.
61. Tan W, Scott D, Belchenko D, Qi HJ, Xiao L. Development and evaluation of microdevices for studying anisotropic biaxial cyclic stretch on cells. Biomed Microdevices. 2008;10(6):869–82. doi:10.1007/s10544-008-9201-8.
62. Tan Y, Tseng PO, Wang D, Zhang H, Hunter K, Hertzberg J, et al. Stiffening-induced high pulsatility flow activates endothelial inflammation via a TLR2/NF-kappaB pathway. PLoS One. 2014;9(7):e102195. doi:10.1371/journal.pone.0102195.
63. Eberth JF, Gresham VC, Reddy AK, Popovic N, Wilson E, Humphrey JD. Importance of pulsatility in hypertensive carotid artery growth and remodeling. J Hypertens. 2009;27(10):2010–21. doi:10.1097/HJH.0b013e32832e8dc8.
64. Eberth JF, Popovic N, Gresham VC, Wilson E, Humphrey JD. Time course of carotid artery growth and remodeling in response to altered pulsatility. Am J Physiol Heart Circ Physiol. 2010;299(6):H1875–83. doi:10.1152/ajpheart.00872.2009.
65. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004;351(16):1655–65. doi:10.1056/NEJMra035488.
66. Sutendra G, Michelakis ED. Pulmonary arterial hypertension: challenges in translational research and a vision for change. Sci Transl Med. 2013;5(208):208sr5. doi:10.1126/scitranslmed.3005428.
67. Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol. 2013;62(25 Suppl):D22–33. doi:10.1016/j.jacc.2013.10.027. Vonk-Noordegraaf’s review outlines the pathophysiology and changes in RV morphology throughout the course of PAH. This focused comprehensive review provides great clinical comparative examples to LV failure, and introduces both mechanical and molecular basis of RV remodeling as well introduces the most recent translational studies.
68. Saouti N, Westerhof N, Postmus PE, Vonk-Noordegraaf A. The arterial load in pulmonary hypertension. Eur Respir Rev. 2010;19(117):197–203. doi:10.1183/09059180.00002210.
69. Sanz J, Garcia-Alvarez A, Fernandez-Friera L, Nair A, Mirelis JG, Sawit ST, et al. Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart. 2012;98(3):238–43. doi:10.1136/heartjnl-2011-300462.
70. Vonk Noordegraaf A, Haddad F, Bogaard HJ, Hassoun PM. Noninvasive imaging in the assessment of the cardiopulmonary vascular unit. Circulation. 2015;131(10):899–913. doi:10.1161/CIRCULATIONAHA.114.006972.
71. Sallach JA, Tang WH, Borowski AG, Tong W, Porter T, Martin MG, et al. Right atrial volume index in chronic systolic heart failure and prognosis. JACC Cardiovasc Imaging. 2009;2(5):527–34. doi:10.1016/j.jcmg.2009.01.012.
72. Badagliacca R, Poscia R, Pezzuto B, Nocioni M, Mezzapesa M, Francone M, et al. Right ventricular remodeling in idiopathic pulmonary arterial hypertension: adaptive versus maladaptive morphology. J Heart Lung Transplant. 2015;34(3):395–403. doi:10.1016/j.healun.2014.11.002.
73. Haddad F, Spruijt OA, Denault AY, Mercier O, Brunner N, Furman D, et al. Right heart score for predicting outcome in idiopathic, familial, or drug- and toxin-associated pulmonary arterial hypertension. JACC Cardiovasc Imaging. 2015;8(6):627–38. doi:10.1016/j.jcmg.2014.12.029. After NIH and REVEAL studies, this is next major clinical research article proposing the newest predictive model based on the RV functionality. Authors used multi-modal imaging and standard clinical indices to assess the multivariate model offering reader to get familiar with the most up-to-date clinical PAH and RV function modalities.
74. Benza RL, Gomberg-Maitland M, Miller DP, Frost A, Frantz RP, Foreman AJ, et al. The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest. 2012;141(2):354–62. doi:10.1378/chest.11-0676. Benchmark study on the REVEAL registry risk score calculator.
75. Champion HC, Michelakis ED, Hassoun PM. Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation. 2009;120(11):992–1007. doi:10.1161/CIRCULATIONAHA.106.674028.
76. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30(20):2493–537. doi:10.1093/eurheartj/ehp297.
77. Swift AJ, Rajaram S, Hurdman J, Hill C, Davies C, Sproson TW, et al. Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry. JACC Cardiovasc Imaging. 2013;6(10):1036–47. doi:10.1016/j.jcmg.2013.01.013.
78. Lankhaar JW, Westerhof N, Faes TJ, Gan CT, Marques KM, Boonstra A, et al. Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. Eur Heart J. 2008;29(13):1688–95. doi:10.1093/eurheartj/ehn103.
79. Hoeper MM, Barbera JA, Channick RN, Hassoun PM, Lang IM, Manes A, et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol. 2009;54(1 Suppl):S85–96. doi:10.1016/j.jacc.2009.04.008.
80. Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114(17):1883–91. doi:10.1161/CIRCULATIONAHA.106.632208.
81. Wells JM, Iyer AS, Rahaghi FN, Bhatt SP, Gupta H, Denney TS et al. Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease. Circ Cardiovasc Imaging. 2015;8(4). doi:10.1161/CIRCIMAGING.114.002546.
82. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation. 2009;119(16):2250–94. doi:10.1161/CIRCULATIONAHA.109.192230.
83. Puwanant S, Park M, Popovic ZB, Tang WH, Farha S, George D, et al. Ventricular geometry, strain, and rotational mechanics in pulmonary hypertension. Circulation. 2010;121(2):259–66. doi:10.1161/CIRCULATIONAHA.108.844340.
84. Badagliacca R, Reali M, Poscia R, Pezzuto B, Papa S, Mezzapesa M, et al. Right intraventricular dyssynchrony in idiopathic, heritable, and anorexigen-induced pulmonary arterial hypertension: clinical impact and reversibility. JACC Cardiovasc Imaging. 2015;8(6):642–52. doi:10.1016/j.jcmg.2015.02.009. Clinically oriented research article by Badagliacca focusing on the RV performance in the setting of PAH. Relatively novel mechanical term of dyssynchrony is adapted to assess the RV prognostic role using non-invasive echocardiographic speckle tissue tracking technique.
85. Redheuil A, Yu WC, Wu CO, Mousseaux E, de Cesare A, Yan R, et al. Reduced ascending aortic strain and distensibility: earliest manifestations of vascular aging in humans. Hypertension. 2010;55(2):319–26. doi:10.1161/HYPERTENSIONAHA.109.141275.
86. Kopec G, Moertl D, Jankowski P, Tyrka A, Sobien B, Podolec P. Pulmonary artery pulse wave velocity in idiopathic pulmonary arterial hypertension. Can J Cardiol. 2013;29(6):683–90. doi:10.1016/j.cjca.2012.09.019.
87. Shujaat A, Bajwa AA, Cury JD. Pulmonary hypertension secondary to COPD. Pulm Med. 2012;2012:203952. doi:10.1155/2012/203952.
88. Mahapatra S, Nishimura RA, Sorajja P, Cha S, McGoon MD. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. J Am Coll Cardiol. 2006;47(4):799–803. doi:10.1016/j.jacc.2005.09.054. Foundational study demonstrating vascular stiffening as a prognostic marker in PH.
89. Barker AJ, Roldan-Alzate A, Entezari P, Shah SJ, Chesler NC, Wieben O, et al. Four-dimensional flow assessment of pulmonary artery flow and wall shear stress in adult pulmonary arterial hypertension: results from two institutions. Magn Reson Med. 2015;73(5):1904–13. doi:10.1002/mrm.25326.
90. Dyverfeldt P, Bissell M, Barker AJ, Bolger AF, Carlhall CJ, Ebbers T, et al. 4D flow cardiovascular magnetic resonance consensus statement. J Cardiovasc Magn Reson. 2015;17(1):72. doi:10.1186/s12968-015-0174-5.
91. Rodriguez Munoz D, Markl M, Moya Mur JL, Barker A, Fernandez-Golfin C, Lancellotti P, et al. Intracardiac flow visualization: current status and future directions. Eur Heart J Cardiovasc Imaging. 2013;14(11):1029–38. doi:10.1093/ehjci/jet086. This imaging focuses review, introduces concept of qualitative and quantitative flow markers obtained by state-of-the-art echocardiographic and MRI techniques. It is focused on both vascular and intracardiac pattern in systemic and pulmonary circuits.
92. Tedford RJ, Hassoun PM, Mathai SC, Girgis RE, Russell SD, Thiemann DR, et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation. 2012;125(2):289–97. doi:10.1161/CIRCULATIONAHA.111.051540.
93. Wentland AL, Grist TM, Wieben O. Review of MRI-based measurements of pulse wave velocity: a biomarker of arterial stiffness. Cardiovasc Diagn Ther. 2014;4(2):193–206. doi:10.3978/j.issn.2223-3652.2014.03.04.
94. Bachler P, Pinochet N, Sotelo J, Crelier G, Irarrazaval P, Tejos C, et al. Assessment of normal flow patterns in the pulmonary circulation by using 4D magnetic resonance velocity mapping. Magn Reson Imaging. 2013;31(2):178–88. doi:10.1016/j.mri.2012.06.036.
95. Reiter G, Reiter U, Kovacs G, Kainz B, Schmidt K, Maier R, et al. Magnetic resonance-derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure. Circ Cardiovasc Imaging. 2008;1(1):23–30. doi:10.1161/CIRCIMAGING.108.780247.
96. Tariq U, Hsiao A, Alley M, Zhang T, Lustig M, Vasanawala SS. Venous and arterial flow quantification are equally accurate and precise with parallel imaging compressed sensing 4D phase contrast MRI. J Magn Reson Imaging. 2013;37(6):1419–26. doi:10.1002/jmri.23936.
97. Reiter U, Reiter G, Kovacs G, Stalder AF, Gulsun MA, Greiser A, et al. Evaluation of elevated mean pulmonary arterial pressure based on magnetic resonance 4D velocity mapping: comparison of visualization techniques. PLoS One. 2013;8(12):e82212. doi:10.1371/journal.pone.0082212.
98. Fenster BE, Browning J, Schroeder JD, Schafer M, Podgorski CA, Smyser J, et al. Vorticity is a marker of right ventricular diastolic dysfunction. Am J Physiol Heart Circ Physiol. 2015;309(6):H1087–93. doi:10.1152/ajpheart.00278.2015.
99. Ky B, French B, May Khan A, Plappert T, Wang A, Chirinos JA, et al. Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure. J Am Coll Cardiol. 2013;62(13):1165–72. doi:10.1016/j.jacc.2013.03.085.
100. Sunagawa K, Maughan WL, Burkhoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol. 1983;245(5 Pt 1):H773–80.
101. Chantler PD, Lakatta EG, Najjar SS. Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise. J Appl Physiol (1985). 2008;105(4):1342–51. doi:10.1152/japplphysiol.90600.2008.
102. Guihaire J, Haddad F, Boulate D, Decante B, Denault AY, Wu J, et al. Non-invasive indices of right ventricular function are markers of ventricular-arterial coupling rather than ventricular contractility: insights from a porcine model of chronic pressure overload. Eur Heart J Cardiovasc Imaging. 2013;14(12):1140–9. doi:10.1093/ehjci/jet092. This translational research oriented manuscript provides comprehensive evidence of the crucial role of the RV in PAH prognosis, and function of the RV-PA axis. Authors investigate in greatly designed study the ventriculo-vascular coupling and compare standard predicting hemodynamic markers.
103. Vanderpool RR, Pinsky MR, Naeije R, Deible C, Kosaraju V, Bunner C, et al. RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension. Heart. 2015;101(1):37–43. doi:10.1136/heartjnl-2014-306142. Clinical study focusing on the RV-arterial coupling signifying the work done by Guihaire et al. (2013). Authors apply basic 2D CMR volumetric imaging in large cohort of patients to investigate the VVCR and further analyzed the prognostic potential. This study is one of the premiere investigations in the clinical setting evaluating considerable amount of patients on RV-PA axis basis.